Concepedia

Author

Anna Biernacka

The University of Texas MD Anderson Cancer CenterORCID

Also Known As

A Biernacka, A. Biernacka, Anna Biernacka, Biernacka, Anna

155

Publications

3.6K

Citations

24

H-Index

64

Concepts

All Affiliations

The University of Texas MD Anderson Cancer CenterUniversity of WarsawThe University of Texas Medical Branch at GalvestonCentre National de la Recherche ScientifiqueBaylor College of Medicine
AB

About

Anna Biernacka is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, cell biology, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

11

1.1K

2

Cell Biology

5

5

584

3

Health Sciences

2

2

66

4

Natural Sciences

2

2

318

5

Cellular Physiology

1

1

34

Anna Biernacka

×

28

Publications

2.4K

Citations

22

H-Index

YearCitations

Aging and Cardiac Fibrosis.

Anna Biernacka, Nikolaos G. Frangogiannis

PubMed

2011

372

Comprehensive Mapping of Histone Modifications at DNA Double-Strand Breaks Deciphers Repair Pathway Chromatin Signatures

Thomas Clouaire, Vincent Rocher, Anahita Lashgari,

Molecular Cell

2018

315

Genome-wide mapping of long-range contacts unveils clustering of DNA double-strand breaks at damaged active genes

François Aymard, Marion Aguirrebengoa, Emmanuelle Guillou,

Nature Structural & Molecular Biology

2017

261

Topoisomerase 1 prevents replication stress at R-loop-enriched transcription termination sites

Alexy Promonet, Ismaël Padioleau, Yaqun Liu,

Nature Communications

2020

182

Endogenous Thrombospondin 1 Protects the Pressure-Overloaded Myocardium by Modulating Fibroblast Phenotype and Matrix Metabolism

Ying Xia, Marcin Dobaczewski, Carlos Gonzalez‐Quesada,

Hypertension

2011

138

Smad3 Signaling Promotes Fibrosis While Preserving Cardiac and Aortic Geometry in Obese Diabetic Mice

Anna Biernacka, Michele Cavalera, Junhong Wang,

Circulation Heart Failure

2015

127

Thrombospondin-1 Induction in the Diabetic Myocardium Stabilizes the Cardiac Matrix in Addition to Promoting Vascular Rarefaction Through Angiopoietin-2 Upregulation

Carlos Gonzalez‐Quesada, Michele Cavalera, Anna Biernacka,

Circulation Research

2013

125

The potential utility of re-mining results of somatic mutation testing: KRAS status in lung adenocarcinoma

Anna Biernacka, Peter Tsongalis, Jason D. Peterson,

Cancer Genetics

2016

113

Combined MEK and VEGFR Inhibition in Orthotopic Human Lung Cancer Models Results in Enhanced Inhibition of Tumor Angiogenesis, Growth, and Metastasis

Osamu Takahashi, Ritsuko Komaki, Paul D. Smith,

Clinical Cancer Research

2012

70

A novel interaction between HER2/neu and cyclin E in breast cancer

Elizabeth A. Mittendorf, Y. Liu, S.L. Tucker,

Oncogene

2010

69

Page 1